Alkermes PLC (ALKS)

20.87 -0.38  -1.79% NASDAQ Dec 13, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/14/2020 08:30 EST Misc Alkermes PLC Fourth Quarter Earnings Conference Call in 2019
02/14/2020 Earnings Alkermes PLC Fourth Quarter Earnings in 2019 Release
10/23/2019 Earnings Alkermes PLC Third Quarter Earnings in 2019 Release
10/23/2019 08:00 EDT Misc Alkermes PLC Third Quarter Earnings Conference Call for 2019
07/25/2019 08:00 EDT Misc Alkermes PLC Second Quarter Earnings Conference Call in 2019
07/25/2019 Earnings Alkermes PLC Second Quarter Earnings in 2019 Release
05/22/2019 12:00 IST Misc Alkermes PLC Annual General Meeting in 2018
04/25/2019 08:30 EDT Misc Alkermes PLC First Quarter Earnings Conference Call in 2019
04/25/2019 Earnings Alkermes PLC First Quarter Earnings in 2019 Release
02/15/2019 Misc Alkermes PLC Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.alkermes.com
  • Investor Relations URL: http://investor.alkermes.com/phoenix.zhtml?c=92211&p=irol-irhome
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 14, 2020
  • Last Earnings Release: Oct. 23, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Top Fund Holders

Symbol Name Weighting
THLSX Thornburg Long/Short Equity I 3.63%
FBT First Trust NYSE Arca Biotech ETF 3.30%
SBIO ALPS Medical Breakthroughs ETF 3.01%
KRXCX Kinetics Medical Adv C 2.63%
FTXH First Trust Nasdaq Pharmaceuticals ETF 1.28%
POAGX PRIMECAP Odyssey Aggressive Growth 1.23%
JEMUX JHVIT Mid Value I 1.20%
HBGHX Hartford Healthcare HLS IB 1.16%
HGHVX Hartford Healthcare R6 1.10%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.